Park Medi World presents a compelling investment case due to its strong regional positioning and consistent operational performance. As the second-largest private hospital chain in North India and the largest in Haryana the company benefits from strategically located hospitals across densely populated regions, ensuring a steady flow of patients. Financially, the company has demonstrated healthy growth, with revenue rising by 13% and profit after tax increasing by 40% between FY24 and FY25. Its margins remain robust, supported by an EBITDA margin of 26.71% and a PAT margin of 15.30%. The company’s expansion-led strategy further strengthens its prospects, as it has a proven ability to acquire stressed hospital assets and turn them profitable within a short timeframe. A significant portion of the IPO proceeds will be directed toward developing new hospitals, expanding existing facilities, and purchasing advanced medical equipment initiatives that are expected to drive long-term growth. Operationally, Park Medi World stands on a strong foundation with over 3,000 beds, 870 ICU beds, 67 operating theatres, and a doctor-led management team with extensive industry experience. From a valuation and returns perspective, the company delivers attractive metrics, including a ROE of 20.68% and ROCE of 17.47%. With improved EPS expected after the IPO due to expanded equity and ongoing growth momentum, the issue holds favorable potential for medium to long-term investors.